Archives
-
Cyanin Chloride in a Human Psoriasis Model
2026-08-28
The 2024 reference study examines cyanin chloride in a cytokine-induced HaCaT psoriasis model and identifies a dual response: suppression of inflammatory signaling and restoration of epithelial barrier-associated endpoints. Its integrated use of radical-scavenging assays, macrophage inflammation testing, keratinocyte transcriptional analysis, STAT3 phosphorylation, TEER, and filaggrin expression provides a useful framework for evaluating anthocyanin compounds in skin disease research.
-
N1-Methylpseudo-UTP for Therapeutic mRNA Design
2026-08-28
N1-Methyl-Pseudouridine-5'-Triphosphate is more than a stability additive: it is a controllable design variable for IVT mRNA. This guide connects nucleotide selection with RNA translation mechanism research, quality control, and localized mRNA therapy decisions.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-08-27
Zhang et al. show that CDC42-dependent epithelial polarity regulates the intestinal stem cell to transit-amplifying cell transition through a YAP/TAZ–epiregulin–mTOR cascade rather than through canonical Wnt signaling alone. The study links tissue architecture to stem-cell fate and identifies EGFR and mTOR as experimentally tractable points for investigating crypt hyperproliferation.
-
UTP Solution (100 mM) for RNA Assay Design
2026-08-27
UTP Solution (100 mM) provides a nuclease-free uridine nucleotide for transcription, RNA amplification, and siRNA workflows. This article explains how to use it thoughtfully when translating TRIM66-dependent olfactory receptor biology into rigorous RNA assay designs.
-
N1-Methylpseudouridine and Translational Fidelity
2026-08-26
The Cell Reports study examined whether N1-methylpseudouridine, a defining modification in COVID-19 mRNA vaccines, changes ribosomal decoding or produces miscoded proteins. Its complementary translation, RNA duplex, and reverse-transcription assays indicate that the modification largely preserves translational accuracy while avoiding some effects associated with pseudouridine.
-
FLOT1–FOSL2–EphA2 Axis in Alzheimer’s Neuroinflammation
2026-08-26
The reference study identifies a FLOT1–FOSL2–EphA2 regulatory axis that promotes pro-inflammatory microglial polarization through p38/MAPK signaling in an APP/PS1 model. Its combination of molecular interaction assays, transcriptional validation, pathway perturbation, and behavioral testing links microglial regulation to neuroinflammation and spatial memory.
-
Digoxin: Na+/K+ ATPase Inhibitor Research Guide
2026-08-25
Digoxin is a cardiac glycoside and Na+/K+ ATPase pump inhibitor that connects ion transport with cardiac contractility modulation. Research also supports cell-specific inhibition of chikungunya virus infection and HIF-1α-associated inflammatory and fibrotic responses, but these findings remain model-dependent.
-
CDC42 Polarity Controls Intestinal Stem Cell Fate
2026-08-25
Zhang et al. show that CDC42-dependent apical-basal polarity controls the intestinal stem cell-to-transit amplifying cell transition through a YAP/TAZ-Ereg-mTOR pathway that operates independently of canonical Wnt signaling. Genetic and pharmacological rescue experiments position EGFR and mTOR downstream of polarity loss, while Scribble deletion supports a broader role for epithelial polarity in crypt homeostasis.
-
CH 223191: From AhR Blockade to Causal Biology
2026-08-24
CH 223191 is an aryl hydrocarbon receptor antagonist for distinguishing AhR-dependent toxicity from downstream correlation. This article interprets ovarian follicle evidence as a causal assay framework for dioxin toxicity mechanism study and broader environmental toxicology research.
-
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-08-24
This study identifies the RNA-binding protein RBMS1 as a regulator of immune-cold triple-negative breast cancer and links its loss to reduced PD-L1 stability. Mechanistically, RBMS1 preserves B4GALT1 mRNA and PD-L1 glycosylation, suggesting a tractable route to strengthen T-cell-based therapies.
-
N1-Methylpseudo-UTP for Stable RNA Workflows
2026-08-23
N1-Methylpseudo-UTP enables a practical comparison between conventional and chemically modified RNA for translation, stability, and RNA-mediated insertion assays. This workflow-focused guide connects improved RNA handling with the repair-pathway insights reported for R2 retrotransposon insertion, while clearly separating established product utility from exploratory genome-engineering applications.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer
2026-08-22
The reference study develops a localized mRNA replacement strategy in which lipid nanoparticles deliver CDKN1A/p21 mRNA directly to orthotopic bladder tumors. Its findings connect restored nuclear p21 expression with cell-cycle suppression, DNA-damage signaling, apoptosis, and reduced tumor growth, while highlighting intravesical administration as a way to limit systemic exposure.
-
WAY-100635: 5-HT1A Assay Workflows
2026-08-21
WAY-100635 provides a selective, silent-antagonist framework for separating 5-HT1A receptor signaling from cannabinoid-driven changes in pain, affect, and cognition. This guide translates receptor-binding, functional, behavioral, and imaging concepts into practical workflows with concentration, handling, and troubleshooting guidance.
-
5-Aminolevulinic acid HCl in Heme Research
2026-08-21
5-Aminolevulinic acid HCl is the hydrochloride salt of 5-amino-4-oxopentanoic acid and an intermediate in heme biosynthesis. Its conversion toward protoporphyrin IX supports pathway studies, photodynamic research, and fluorescence-guided tumor resection, while recent Salmonella research links haem regulation to macrophage evasion.
-
LG 101506 for RXR Signaling Research
2026-08-20
LG 101506 provides a controllable small-molecule entry point for studying RXR-dependent transcription, differentiation, and metabolism regulation. This workflow pairs RXR perturbation with orthogonal PD-L1 and RBMS1 assays to distinguish established TNBC biology from exploratory cross-domain hypotheses.